Source: CFN Media Group

Jazz Pharmaceuticals, Inc: Jazz Pharmaceuticals Announces Significant New Investment in UK Manufacturing

Construction begins on a new state-of-the-art manufacturing facility at Kent Science Park designed to support the manufacture of regulatory approved cannabis-based medicines This represents a significant commitment to the UK by GW Pharmaceuticals, now part of Jazz Pharmaceuticals, investing $100 million (£75m) and creating more than 100 highly skilled jobs LONDON, March 25, 2022 /PRNewswire/ - Jazz [...]The post Jazz Pharmaceuticals Announces Significant New Investment in UK Manufacturing appeared first on CannabisFN.

Read full article »
Est. Annual Revenue
<$1M
Agree?
Est. Employees
<10
Agree?
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100